Price Reductions for 300 Medicines in Morocco: Details of the New Government Decision

Implementation of the New Legal Framework for Regulating Medicine Prices in Morocco

As part of the Ministry of Health and Social Protection’s efforts to regulate the pharmaceutical market, it has been announced that retail prices for nearly 300 medicines will be reduced. This decision comes less than two months after the publication of the new regulatory framework in the Official Gazette, which defines the rules and mechanisms for calculating medicine prices in the Kingdom.

Details of Expected Reductions in the Pharmaceutical Sector

According to a responsible source within the Ministry, this move is the first concrete application of new laws aimed at enhancing access to medicine and easing the financial burden on patients. This list serves as the first practical implementation of the recently enacted legal texts, where 300 pharmaceutical products will undergo price reviews according to the newly adopted standards.

Context of the Medicine Price Review

This approach is based on establishing a national policy that seeks to regulate the pharmaceutical sector more strictly and ensure price competitiveness to support the purchasing power of Moroccan citizens. Observers emphasize that these reductions reflect a desire to align prices with current economic and social realities while ensuring the continued availability of medicines in national pharmacies.

It should be noted that this process is part of an ongoing series of legislative reforms led by the supervisory ministry to modernize the legal arsenal governing the health sector, with further measures regarding additional medicine categories expected in the near future.